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Abstract
Nicotine exerts its reinforcing action by stimulating nicotinic acetylcholine receptors (nAChRs) and boosting dopamine (DA)
output from the ventral tegmental area (VTA). Recent data have led to a debate about the principal pathway of nicotine
action: direct stimulation of the DAergic cells through nAChR activation, or disinhibition mediated through desensitization
of nAChRs on GABAergic interneurons. We use a computational model of the VTA circuitry and nAChR function to shed light
on this issue. Our model illustrates that the a4b2-containing nAChRs either on DA or GABA cells can mediate the acute
effects of nicotine. We account for in vitro as well as in vivo data, and predict the conditions necessary for either direct
stimulation or disinhibition to be at the origin of DA activity increases. We propose key experiments to disentangle the
contribution of both mechanisms. We show that the rate of endogenous acetylcholine input crucially determines the
evoked DA response for both mechanisms. Together our results delineate the mechanisms by which the VTA mediates the
acute rewarding properties of nicotine and suggest an acetylcholine dependence hypothesis for nicotine reinforcement.
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Introduction
The ventral tegmental area (VTA) is a key dopaminergic
structure for signaling reward and motivation as well as for the
acquisition of drug-reinforced behavior [1,2]. Nicotine (Nic)
stimulates nicotinic acetylcholine receptors (nAChRs) in the
VTA [3] boosting dopamine (DA) output to its targets such as
the nucleus accumbens [4] and thereby playing a cititcal role in
the mediation of nicotine reward and dependence [5–7]. Yet,
despite a wealth of data on the outcome of nicotine action, the
precise mechanisms by which nicotine usurps control over DA
signaling remain debated.
Release of endogenous acetylcholine (ACh) from cholinergic
projections [8] causes activation of nAChRs in the VTA [9]. The
rapid breakdown of ACh by acetylcholinesterase precludes
significant nAChR desensitization [9,10]. Exogenous nicotine is
not hydrolyzed [11] and thus activates and subsequently
desensitizes nAChRs within seconds to minutes [10,12]. The
various subtypes of nAChRs exhibit markedly different activation/
desensitization kinetics and distinct affinities for ACh and Nic, as
well as different expression targets [7,13]. The low-affinity a7
subunit-containing nAChRs desensitize rapidly (,ms) [14] and
are found in the VTA presynaptically on the glutamatergic
terminals [15]. The high-affinity a4b2 subunit-containing
nAChRs desensitize relatively slowly (,sec) and are located
postsynaptically on the DA and GABAergic cells [13]. Studies on
knockout mice suggest that the a4b2 nAChRs mediate most of the
Nic-evoked currents and the acute reinforcing effects of nicotine
[16], while a7 nAChRs appear to contribute to the fine-tuning of
the DA response to nicotine [17].
A major outstanding question is whether nicotine acts directly
on the DA neurons through the activation of a4b2 nAChRs or
affects the local GABA interneurons and thereby the inhibition of
DA neurons. In vitro data suggest that the increased activity of DA
neurons is due to nicotine desensitizing the a4b2 nAChRs,
decreasing the endogenous cholinergic drive to GABA neurons
and resulting in disinhibition of DA cells [18,19]. In vivo studies
emphasize the role of nicotine-evoked direct activation of b2-
containing nAChRs expressed on the DA neurons [17].
We set out to clarify the mechanisms linking the nicotine-
triggered nAChR activation/desensitization and nicotine control
of DA signaling. In order to do so we built a neuronal network
model that includes the afferent and local VTA connectivity as
well as the location and activation/desensitization properties of the
different nAChR subtypes. Our results show that each of the two
mechanisms, direct excitation and disinhibition, requires distinct
conditions for afferent input strengths and cellular properties in
order to account for the nicotine-evoked DA boost. We develop a
series of experimental protocols to disambiguate the disinhibition
vs. the direct stimulation pathways and reveal that the endogenous
cholinergic input rate dictates the DA response to nicotine for
both.
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Results
Our minimal local circuit model of the VTA reflects the
glutamatergic (Glu) and cholinergic (ACh) afferents to the DA and
GABA cells in the VTA, as well as local inhibition of DA cells by
GABA neurons (see Fig. 1A). Importantly we explicitly model the
subtype-specific activation and desensitization of a4b2 and a7
nAChRs since these subtypes have been shown to be predominant
in mediating nicotine effects in the VTA [13,16,17]. Further
evidence supports the critical role of a4-containing nAChRs for
Nic action in the VTA [20,21]. Based on available data we model
the a7 nAChRs as placed at presynaptic Glu terminals where they
affect Glu input strength [15]. We model the a4b2 nAChR as
placed somatically on both the DA and the GABA neurons. The
relative a4b2 nAChR expression level (DA/GABA proportional
density) is controlled in our model by a fraction parameter r which
allows us to shift continuously the balance of a4b2 nAChR-
mediated effects from GABA cells (r~0) to DA cells (r~1;
Fig. 1A). Overall, the model augments the mean-field firing-rate
description of the relevant neuronal populations with subtype
specific receptor currents in order to study neuronal activity in
response to endogenous (ACh) and exogenous (Nic) ligands acting
on nAChRs (see Models).
Kinetics of the subunit-specific nAChR model in response
to Nic and/or Ach
Since the nAChRs are the exclusive points of action for Nic that
affect DA activity in the VTA, a model of the nAChR that
incorporates the response properties of the considered receptor
subtypes is key for our approach. In addition, since the circuit
model describes the mean activities of the DA and GABA
neuronal populations, we describe the average macroscopic
receptor-mediated currents as opposed to the fine details of single
receptor kinetics and pharmacology. Accordingly, the receptor
activation is elicited by the mean input rate of endogenous ACh
release which is expressed as a concentration. We use a classical 4-
state model of the nAChR adapted from Katz and Thesleff
[22,23] (see Text S2.) briefly described in [24]) accounting for
subtype-specific activation and desensitization as recorded in
response to Nic and ACh [25–30].
Fast nAChR activation in response to acetylcholine and/or
nicotine (transition from deactivated/sensitized to activated/
sensitized in the model; see Fig. 1B) gives rise to an initial peak
current, and the slower desensitization reduces the current during
sustained presence of the agonist (Fig. 2A and B for a4b2 and a7,
respectively). After wash-out of agonists, the receptor recovers to
the deactivated/sensitized state within seconds-to-minutes [7,13]
(see insets in Fig. 2A and B).
In order to account for the response differences between the two
considered nAChR subtypes, two distinct sets of parameters were
identified (see Models with respect to details of the parameter
adjustment). Most importantly, the potency of nicotine and
acetylcholine for the a4b2 nAChR is much higher than for the
a7 nAChR (see dose-response curves in Fig. 2C and D). Hence the
a4b2 but not the a7 nAChRs shows a partial response at the
relatively low, physiologically relevant Nic concentration of
0.5 mM [11,31] (indicated in Fig. 2C and D).
Both receptor subtypes show distinct temporal desensitization
dynamics. Desensitization is relatively slow for a4b2 nAChRs:
a4b2 nAChR-mediated currents decrease slowly over the course
of agonist exposure (Fig. 2A) and the receptor recovers slowly
(,10 min) from the desensitized state after removal of the agonist
(inset in Fig. 2A). On the contrary, at high agonist concentrations
fast desensitization of a7-containing receptors completely sup-
presses the evoked current on the time scale of ,100 ms (Fig. 2B)
and the receptor recovers from desensitization within ,2 min
(inset in Fig. 2B).
The a4b2- and a7-nAChR model responses to ACh show
another crucial difference when a physiologically relevant
concentration of Nic is present (0.5 mM, Fig. 2E). Pretreatment
with Nic reduces the half-maximum response by ,73% for a4b2
nAChRs, whereas this response decreases only by ,13% for a7
nAChRs (Fig. 2E). This is due to the lower potency of Nic for
desensitizing a7 nAChRs as compared to a4b2 nAChRs, i.e.,
IC50
a7&IC50a4b2 (see Models and Table 1). As a result, a smaller
fraction of a7 nAChRs is driven into the desensitized state. Please
note that the desensitized fraction of a4b2 nAChRs is,70%; their
response is not completely abolished at 0.5 mM Nic. While Nic
reduces the maximum amplitudes for both receptors, it does not
affect the effective half-maximum ACh concentrations [24]. In the
absence of ACh, Nic evokes a small activation of the receptors [24]
that has also been seen experimentally for a4b2 nAChRs [12].
In summary, the simple nAChR model is constrained to capture
the key properties of the subtype specific responses to Nic and
ACh. Most significant for this study is that Nic at physiologically
relevant concentrations significantly activates and desensitizes
a4b2 but not a7 receptors.
Data used to constrain the model parameters are obtained in
the absence of acetylcholinesterase [25–30]. Under such condi-
tions, persistent presence of Nic and of ACh both activates and
desensitizes the nAChRs in the model. However, rapid ACh
hydrolysis and a higher efficiency of Nic to desensitize the receptor
seem to prevent ACh from desensitizing nAChRs in vivo [9,10,32].
In the following, we model conditions where acetylcholine is
rapidly hydrolyzed and drives only the transition from deactivated
to activated state (see Fig. 1B and C), hence desensitization is
driven by nicotine only. We also investigate, later in the
manuscript, how our results are affected in case of low
acetylcholinesterase activity, that is, when also ACh drives
receptor desensitization (see ‘‘ACh-driven desensitization through
low acetylcholinesterase activity’’).
The VTA responses to nicotine in vitro and in vivo
We next ask whether we can identify the specific circuit-level
pathways of nicotine action in the VTA all the while reconciling
the in vitro and in vivo data. First we show that the VTA model
endowed with the description of the nAChR dynamics captures in
Author Summary
Nicotine is the major addictive substance in tobacco
smoke. Nicotine exerts its control over neural circuits
through nicotinic acetylcholine receptors that normally
respond to endogenous acetylcholine. Activation of
dopamine neurons in the mesolimbic dopaminergic
circuits, which signal motivational properties of actions
and stimuli, is at the heart of mediating nicotine reward
and dependence. However, major questions have re-
mained unsettled over the precise mechanisms by which
nicotine usurps dopaminergic signaling: through receptor
activation on dopamine neurons or through receptor
desensitization on local inhibitory interneurons. Here we
reconcile this debate by showing that both mechanisms
are possible. Most notably we present a novel hypothesis
suggesting that the mechanisms for nicotine action are
state-dependent; they are controlled by the rate of the
endogenous cholinergic input to the dopaminergic
circuits.
Cholinergic Input Governs DA Response to Nicotine
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vitro nicotine evoked modulation of excitatory and inhibitory inputs
to DA neurons [18,19]. We then demonstrate that a simple change
in the constant afferent input strengths allows the model to also
account for in vivo DA responses in both wild type and nAChR
knockout mice [17].
Nicotine-dependent modulation of excitatory and
inhibitory input to DA cells in vitro
Recordings from DA neurons in VTA slices show that bath
application of 1 mM nicotine initially increases the frequency of
IPSCs followed by a drop below baseline after Nic perfusion [19].
Furthermore, 1 mM nicotine evokes a robust enhancement of the
spontaneous EPSC frequency in DA neurons [18]. To account for
these data we start out by setting the afferent input strength to
relatively low levels which characterizes the in vitro situation
(illustrated by the scissors in Fig. 3A and B).
In line with experiments, the nicotine-evoked initial increase of
inhibition and subsequent drop below baseline are exclusively
mediated by a4b2 nAChRs (Fig. 3C). The a4b2 nAChRs located
on VTA GABAergic cells are activated by application of 1 mMNic
for 2 min. This increases the GABAergic population activity and
in turn leads to an increase in the GABA input (IGABA) to the DA
cells (see green lines in Fig. 3C and E). The first peak of this
response arises from fast receptor activation counterbalanced by
slower desensitization. The subsequent steady and smaller increase
follows the time course of Nic concentration build-up (Fig. 3C).
After washout of the drug, a significant fraction of nAChRs
remains desensitized and recovers at a slow time-scale (Fig. 3C).
This desensitized fraction of nAChRs reduces the GABA cell
response to the constant cholinergic input so that IGABA falls below
baseline after nicotine is removed (illustrated in magenta in Fig. 3C
and E). The recovery time course is governed by the maximal
desensitization time constant, tmax, of a4b2 nAChRs. Based on
experimental data, that time constant was set to approximately
10 min (see Table 1; [17,19]). To account for the block of Glu
transmission during these experiments we set wGlu~0 (see
Models).
As expected, blocking a4b2 nAChRs in our model abolishes the
Nic-evoked modulation in IPSC frequency (cyan line in Fig. 3E,
[19]). In contrast, the a7 nAChRs have little or no impact on the
response (green line and orange square in Fig. 3E, [19]). Our
model accounts for the in vitro data in both the control, the a4b2-
Figure 1. Scheme of the ventral tegmental area and the states of nicotinic acetylcholine receptors. (A) Afferent inputs and circuitry of
the ventral tegmental area (VTA). The GABAergic neuron population (red) inhibits locally the dopaminergic neuron population (DA, green) [40,43,44].
This local circuit receives excitatory glutamatergic input (blue lines) from the prefrontal cortex (PFC) [68–71], the laterodorsal tegmental nucleus (LDT)
and the pedunculopontine tegmental nucleus (PPT) [72–74]. The LDT and the PPT furthermore furnish cholinergic projections (cyan lines) to the VTA
[8]. nAChRs are found at presynaptic terminals of glutamatergic projections (a7-containing receptors), on GABAergic neurons (a4b2 nAChRs) and DA
neurons (a4b2 nAChRs). r is a parameter introduced in the model to change continuously the dominant site of a4b2 nAChR action. Dopaminergic
efferents (green) project, amongst others, to the nucleus accumbens and the PFC. (B) Two-gate model of nicotinic acetylcholine receptors. Activation
(horizontal) and desensitization (vertical) of nAChRs are two independent transitions in the model, i.e, the receptor can exist in four different states: (i)
deactivated/sensitized (up-left), (ii) activated/sensitized (up-right), (iii) deactivated/desensitized (down-left), and (iv) activated/desensitized (down-
right). Activation is driven by Nic and ACh and induces a transition from the deactivated/sensitized to the activated/sensitized state (green), the only
open state in which the receptor mediates an excitatory current. Desensitization is driven by Nic and ACh if gw0. a and s characterize the fraction of
nAChRs in the activated and the sensitized state, respectively (modified from [22]). (C) a4b2 nAChR state occupation as described by the model for
different Nic and ACh concentrations (g~0). The area of the circles represents the fraction of receptors in each of the four states (alignment as in
panel B). The occupation of receptor states is shown for long-term exposures to low (0.1 mM) and high (100 mM) ACh, without and with 1 mM
nicotine. A star means that the respective state is not occupied.
doi:10.1371/journal.pcbi.1003183.g001
Cholinergic Input Governs DA Response to Nicotine
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and the a7-nAChR blocked conditions. Note that in order to do
so, the average cholinergic drive to the GABAergic cells needs to
be set at ACh~0:384 mM, giving a 300% increase of GABAergic
input at 1 mM Nic. The drop below baseline in our simulations
matches experimental data without further fitting of the model
(Fig. 3E).
The present model furthermore accounts for the increase of
glutamatergic (IGlu) input to the DA cells in response to a 2 min
application of 1 mM Nic under GABA block (Fig. 3D). This
concentration-dependent increase stems from activation of the
presynaptic a7 nAChRs by nicotine (Fig. 3F). The model accounts
for a number of experimental data: in control condition (green line
and squares), in the presence of an a7 nAChR specific antagonist
(orange line and square), and in the presence of an antagonist for
non- a7 nAChRs (green line and cyan square).
To account quantitatively for the nicotine-induced increase in
Glu input to DA cells (IGlu max=IGlu 0) we set the mean firing rate
of the Glu afferents (vGlu~5:69:10
{4) such that the relative
increase attains 325% of baseline level. This intermediate value
satisfies the experimental data obtained both in the control case
(400% increase) and with the a4b2 nAChRs blocked (275%
increase, see [19] and Fig. 3F). In the model, blocking the a4b2
nAChRs does not have an effect on the Glu input change since the
nicotine-dependent increase stems from activation of a7 nAChRs
Figure 2. Nicotinic acetylcholine receptor model responses to nicotine and acetylcholine. Response properties of a4b2 (panels A,C,E) and
a7 nAChRs (panels B,D,E). (A&B) Dynamics of a4b2- (A) and a7-containing nAChRs (B) in response to Nic. The dynamics of the activation, a, (purple
lines) and sensitization, s, (orange lines) are shown during and after the exposure to a constant Nic concentration of 100 mM for 200 ms starting at
t~50 ms. The normalized receptor activation, n~a:s, is shown in blue and is proportional to the actual current. The inset shows the dynamics of the
same variables on a longer time scale. (C&D) Dose-response curves of a4b2- (C) and a7-containing nAChRs (D) in response to Nic and ACh. The peak
current mediated by the receptor during a 200 ms exposure to the respective agonist concentration is shown. The responses to Nic (ACh) are
depicted in blue (red). The arrows indicate physiologically relevant nicotine concentrations [11,31]. The half-maximum effective concentrations for
ACh-evoked responses are indicated by the dotted black lines. (E) Reduction of the half-maximum response evoked by ACh in the presence of 0.5 mM
Nic. The half-maximum effective concentration of the peak current in the absence of Nic is ACh~29 mM for a4b2, and ACh~67 mM for a7 nAChRs
(green bars, see C and D). The red bars show the peak current in response to the same ACh concentration in the presence of a constant concentration
of Nic~0:5 mM. See Table 1 for parameters.
doi:10.1371/journal.pcbi.1003183.g002
Cholinergic Input Governs DA Response to Nicotine
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only (Fig. 3B, D and F). We use the ACh rate as fixed above
(ACh~0:384 mM) which results in a weak activation of a7
nAChRs on average in the absence of nicotine.
In summary, we show that the model reproduces the relative
change in IPSC and EPSC frequency to VTA DA neurons during
in vitro nicotine perfusions. The model also accounts for the supra-
linear (increasing slope) increase in EPSC frequency in the
nicotine range from 0.1 to 1 mM Nic (green line and squares in
Fig. 3F) and predicts a sub-linear increase (decreasing slope) for the
IPSC frequency in the same range of nicotine (Fig. 3E). This
difference stems from the dissimilar potencies of Nic for the a7 and
the a4b2 receptors: the high Nic potency a4b2 starts to saturate in
this range.
Nicotine-evoked increase of DA cell activity in vivo: Direct
stimulation vs. disinhibition mechanisms
To translate the VTA circuit model to in vivo conditions, we kept
all parameters fixed and modified only the afferent input strength.
This ‘‘increased input’’ model accounts for the following in vivo
data : (i) An intravenous injection of nicotine in wild-type mice
increases the firing rate of DA cells. (ii) This increase is completely
abolished in a4b2 knockout mice and is only weakly diminished in
a7 knockout mice [17].
We identify two different plausible model regimes that could
address the in vivo experiments. The scenario in which a4b2
nAChR-mediated action is predominantly exerted through
activation on the DA cells is referred to as ‘‘direct stimulation’’
(Fig. 4A). The scenario where a4b2 nAChRs mainly influence the
GABAergic activity through desensitization we term ‘‘disinhibi-
tion’’ (Fig. 4B). The model can be shifted between these scenarios
by a change in the relative expression levels of a4b2 nAChRs on
the DA and the GABA neurons using the parameter r. To
illustrate the qualitative behavior of the model in each scenario, we
use r~0:8 for direct stimulation and we set r~0 for disinhibition.
We do not use the extreme case (r~1) for direct stimulation since
the existence of a4b2 nAChRs on GABA cells has been shown
experimentally [19,33]. In general, the conditions for direct
stimulation are met as long as rw0:5 and for disinhibition for
rv0:5 (see below).
Direct Stimulation (single cell level mechanism; r~0:8) : Our
simulations reveal two important requirements necessary for direct
stimulation to produce a boost of the DA activity on time scales
observed in the data [17]. First, the cholinergic input rate to the
VTA has to be low, activating the a4b2 nAChR only weakly
(ACh~0:1 mM; ACh%EC50a4b2 and ACh&IC50a4b2). Nic can
further activate these nAChRs. Second, we see that the duration of
elevated DA activity cannot outlast the presence of Nic (here
1 mM, Fig. 4C), implying that in this scenario the time-course of
DA activity is directly determined by the time course of Nic in the
VTA.
When the endogenous ACh input rate is increased
(ACh~1:77 mM), Nic produces only a very brief initial peak
followed by a sustained depression of the DA activity (dashed blue
line in Fig. 4C). In general we find that as long as more a4b2
nAChRs are expressed on DA than on GABA neurons (rw0:5),
the cholinergic input rate has to be below 0.38 mM in order to
observe a net increase of DA activity in response to Nic application
(note that we define a DA increase as a positive integral of the
difference between the nicotine-modulated- and the baseline DA
activity,
Ð T
0
(nD(t){nD 0)dtw0).
Table 1. Parameters of nAChR activation and desensitization kinetics.
Parameter Definition Value Reference
a7-containing nAChR
EC50 half-maximum conc. of activation 80 mM [25,27,29,30]
a potency of nicotine to evoke response ,2 [30,75]
na Hill coefficient of activation 1.73 [25,29,30]
IC50 half-maximum conc. of desensitization by Nic 1.3 mM [25,30]
nd Hill coefficient of desensitization 2 [25]
ta activation time constant 5 msec [29]
Kt half-maximum conc. of desensitization time constant 1.73 mM [25]
nt Hill coefficient of des. Time constant 2 [25]
tmax maximal des. time constant 2 min [25]
t0 minimal des. time constant 50 msec this study, [29]
a4b2-containing nAChR
EC50 half-maximum conc. of activation (ACh) 30 mM [28]
a potency of Nic to evoke response ,3 [26,28]
na Hill coefficient of activation 1.05 [25,28]
IC50 half-maximum conc. of desensitization by Nic 0.061 mM [25]
nd Hill coefficient of desensitization 0.5 [25]
ta activation time constant 5 msec [28]
Kt half-maximum conc. of desensitization time constant 0.11 mM [25]
nt Hill coefficient of des. Time constant 3 [25]
tmax maximal des. time constant 10 min this study
t0 minimal des. time constant 500 msec this study, [28]
doi:10.1371/journal.pcbi.1003183.t001
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Figure 3. Model VTA responses to nicotine in vitro. Left hand panels (A,C,E and left side of panel G) show the results on GABAergic input
changes to VTA DA cells, while the panels on the right-hand side (B,D,F and right side of G) depict results on glutamatergic input increases to VTA DA
cells in response to 1 mM nicotine for 2 min starting at t = 1 min. (A&B) Illustration of the simulated experimental situation during in vitro
experiments. Grey shaded parts and black crosses show pharmacologically blocked transmission pathways, and the scissors illustrate the truncation
of the input pathways in vitro. (C&D) Time course of GABAergic, IGABA, (C) and glutamatergic input, IGlu, (D) changes to VTA DA neurons during and
after Nic exposure (black bar on top of the panels, Nic time-course shown in insets). The increase (green) and the decrease (magenta in C) of the input
currents with respect to baseline are illustrated in both panels. (E&F) Maximal change of GABAergic (E) and glutamatergic input currents (F) as a
function of the Nic concentration applied. The lines show the results of the model for control conditions (in green in both panels and magenta for
decrease in panel E), with a4b2 nAChRs blocked (cyan in panel E, and green in panel F), and with a7 nAChRs blocked (green and magenta in panel E,
orange in panel F). The squares show experimental results adapted from [19] (E) and [18] (F) for different experimental situations : control conditions -
green squares; with a7 nAChR specific antagonist - orange squares; and with antagonist for non- a7 nAChRs - cyan squares. (G) Comparison of
Cholinergic Input Governs DA Response to Nicotine
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Disinhibition (circuit level mechanism; r~0) : Our simulations
reveal two conditions necessary for the GABA-dependent mech-
anism of nicotine-evoked DA activity increases. First, we observe
that in order for a 2 min exposure to 1 mM Nic to boost DA
activity sufficiently to account for the data, the endogenous
cholinergic input to the VTA must be high (ACh~1:77 mM,
Fig. 4D). Such cholinergic drive assures that nicotine mainly drives
a4b2 receptor desensitization after a brief initial period of
activation (Fig. 4D,F). Second, the nicotine-induced desensitiza-
tion suppresses the GABAergic cell response to ACh, reducing it
below baseline during and after the exposure to Nic (Fig. 4F, full
lines). The return to baseline that follows the Nic removal is
governed by the maximal desensitization time constant of a4b2
nAChRs (tmax; Fig. 4D,F for three different values of tmax). The
duration of the DA boost therefore outlasts the presence of Nic as
it depends on the recovery of a4b2 nAChRs from desensitization
and thereby the removal of inhibition.
When the ACh drive is decreased in the disinhibition case, the
DA activity shows a drop below baseline (Fig. 4D, dashed blue
line, ACh~0:1 mM), mirroring an increase of GABA cell activity
(dashed blue line in Fig. 4F). In general, we find that the
endogenous cholinergic input has to be larger than
ACh§0:18 mM in order to see an increase of DA activity in
response to Nic.
Our model points out that the two pathways can be
disambiguated by the relative dynamical profiles of the DA and
GABA neuron responses to nicotine. For the direct stimulation,
the activity of the GABAergic neurons (Fig. 4E) matches the DA
neuron activity but with a smaller amplitude (due to the smaller
fraction of a4b2 nAChRs on GABAergic cells, r~0:8). The
disinhibition circuit, on the other hand, shows that the profile of
DA activity is a mirror-image of the GABAergic activity (compare
Fig. 4D and F). For the level of Nic used in our simulations the DA
neurons are slaved to the GABA neurons since only the high
potency a4b2 receptors on GABA neurons are recruited.
In summary, we demonstrate that direct stimulation, through
receptor activation, and disinhibition, through receptor desensiti-
zation, require distinct conditions in order to account for nicotine-
induced DA activity changes in wild type, a4b2-, and a7-knockout
mice (see summary in Fig. 4G). Endogenous cholinergic input rate
has to be low for direct stimulation and high for disinhibition. Our
simulations further uncover a tell-tale difference in the time course
of the DA activity: for direct stimulation the duration of nicotine
presence directly determines the duration of the DA response,
whereas for disinhibition the recovery from desensitization of the
a4b2 nAChRs defines the temporal scale of the DA activity. For a
given duration of nicotine application these results predict longer-
lasting increases in DA activity with disinhibition as compared to
direct stimulation (in our model the difference is on the order of
12 min, Fig. 4H).
Predictions and experimental protocols to pin down the
major pathway of nicotine action
In view of our results, the experimental data available so far are
not sufficient to determine conclusively to what extent direct
stimulation or disinhibition of DA cells is at the origin of DA
responses to Nic. In addition to the differences we uncover above,
we propose a series of feasible experiments to conclusively
determine whether direct stimulation or dishinibition of DA cells
is at the origin of DA responses to Nic. First, we examine the DA
cell response for a range of endogenous cholinergic input rates and
nicotine concentrations. We then vary the balance of a4b2
nAChRs between DA and GABA cells and investigate the DA
response to Nic in the in vitro (low endogenous ACh input) and the
in vivo (high endogenous ACh input) regimes.
In the first set of experiments we suggest to measure how the
DA response to physiologically relevant nicotine injections (e.g.,
1 mM Nic) depends on the endogenous ACh input rate. The
endogenous ACh rate could be manipulated by stimulation or
inhibition of activity in the laterodorsal tegmental nucleus or the
pedunculopontine tegemental nucleus (Fig. 1A). We predict that
for direct stimulation, the DA response should decrease with rising
ACh input rate (Fig. 5A,C). In contrast, disinhibition implies that
the total boost in DA activity should increase with the ACh input
(Fig. 5B,C). These differences are explained as follows: the ACh
drive sets the basal level of activated a4b2 nAChRs and available
to be desensitized. At high ACh levels, for direct stimulation, the
Nic-induced desensitization of a4b2 nAChRs reduces the excit-
atory drive to the DA, depressing the DA activity. In contrast,
under disinhibition, a4b2 nAChR desensitization decreases the
excitatory drive to the GABA cells (Fig. 5B,C), removing the
inhibition to the DA population and hence liberating the DA
activity. Consequently, the boost of DA activity would become
more pronounced under high ACh input rates. The result that the
endogenous ACh input rate determines the nAChR-mediated
action of Nic holds for a large range of receptor characterizations
when actylcholinesterase activity is high (see below and Text S1).
A second set of experiments should examine the dependence of
DA activity on the injected Nic dose at a pre-set endogenous ACh
input rate. Our model indicates that the two pathways imply
distinct time scales for the maximal DA activity. Direct stimulation
results in a DA peak directly at the onset of Nic injection (Fig. 5D),
whereas the disinhibition case gives a delayed peak after the Nic
clearance (Fig. 5E). Moreover, for direct stimulation, the peak
amplitude of the maximal DA response increases with rising Nic
dose, but levels off rapidly (at ,0.5 mM nicotine) for the
disinhibition case (Fig. 5F). Again, the difference is explained by
the dynamics of the a4b2 receptor in response to nicotine. The
maximal increase for direct stimulation is due to fast activation of
a4b2 nAChRs, whereas in the disinhibition case, the increase
arises due to the delayed desensitization of these receptors. For
direct stimulation, higher nicotine levels result in stronger receptor
activation and an increase in peak amplitude. In contrast, the
fraction of receptors driven into the desensitized state saturates at
lower Nic for disinhibition with the peak amplitude saturating.
This is because the maximal fraction (IC50%0:5 mM) and the
minimal rate of desensitization, t0, (Ktv0:5 mM) are already
attained at ,0.5 mM nicotine (see Table 1). Note that in these
simulations Nic is applied for 2 min in the case of disinhibition and
for 10 min in the case of direct stimulation in order to achieve
comparable durations of DA activity increases (compare Fig. 4H).
Shifting the balance of the a4b2 nAChR action between the DA
and the GABA cells allows to further clarify how the interplay
between a4b2 nAChR expression and cholinergic input levels
relative input changes between model and experiment for the case of 1 mM nicotine for 2 min. Model results are shown with shaded bars and
experimental results with filled bars. Both, GABAergic- (left) and glutamatergic input changes (right) are shown for the three discussed cases : control
conditions - green and magenta, a4b2 nAChR blocked - cyan, and a7 nAChR blocked - orange and magenta (experimental data adapted from [18,19];
ACh~0:384 mM and vGlu~5:68:10{4 in all panels, see Table 1 and Models section for other parameters).
doi:10.1371/journal.pcbi.1003183.g003
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Figure 4. Model VTA responses to nicotine in vivo. Panels on the left-hand side (A,C,E) show results of the direct stimulation scenario
(I0~0:0202, ACh~0:1 mM, vGlu~0:1) and panels on the right-hand side (B,D,F) depict results for disinhibition (I0~0:1, ACh~1:77 mM, vGlu~0:1).
(A&B) Illustration of the simulated experimental situation in vivo. Note the difference in a4b2 nAChR distribution between the direct stimulation (A,
r~0:8) and the disinhibition case (B, r~0). (C&E) Normalized DA (C) and GABA neuron activity (E) in response to the application of 1 mM nicotine in
case of direct stimulation. The full lines show the time course of the normalized nD (C) and nG (E) for three different durations of nicotine exposure,
TNic (as indicated by the bar on top of C). The full and the dashed blue lines depict the responses for low (ACh~0:1 mM) and high endogenous
cholinergic input rates (ACh~1:77 mM), respectively (TNic~10 min). (D&F) Normalized DA (D) and GABAergic neuron activity (F) in response to 1 mM
nicotine for 2 min in case of disinhibition. The full lines show the time course of the normalized nD (D) and nG (F) for three different maximal
desensitization time constants of a4b2 nAChRs, tmax (as indicated in the upper panel). The full and the dashed blue lines depict the responses for
high (ACh~1:77 mM) and low cholinergic input rates (ACh~0:1 mM), respectively (tmax~10 min). (G) Comparison of model results (purple and
orange bars) and experimental data (green bars) on relative DA neuron activity changes in response to 1 mM nicotine. The maximal relative increase
of DA activity in wild type (TNic~10 min for direct stimulation; and TNic~2 min with tmax~10 min for disinhibition) and mutant mice is shown
(experimental data adapted from [17]). (H) Comparison of the total duration of elevated DA neuron activity with respect to the duration of Nic
application, TNic . The duration of elevated activity is taken to be the time between the two points where nD attains half-of-maximum activity (as
illustrated by arrows in C and D and depicted by square and circle, respectively). This duration is plotted for direct stimulation (purple) and
disinhibition (orange).
doi:10.1371/journal.pcbi.1003183.g004
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conjointly determine DA activity. In order to do so, we study the
acute DA response to 1 mM nicotine for in vitro (Fig. 6A) and in vivo
conditions (Fig. 6B) while varying the value of r continuously. For
the in vitro regime (low afferent input), the net DA activity is
increased as long as rw0:5 (e.g., direct stimulation case: r~0:8, red
curve in Fig. 6A). On the other hand, in vivo (high afferent input) a
net DA increase (after a small negative transient) requires rv0:5
(e.g., disinhibition case: r~0, blue curve in Fig. 6B). The extent to
which a4b2 nAChR mediated effects inhibit DA cells for low
(GABA mediated inhibition for rv0:5, Fig. 6A) and high
(desensitization of a4b2-mediated inhibition for rw0:5, Fig. 6B)
endogenous ACh input scenarios depends on the strength of the
glutamatergic input to DA cells. In the model, we set the ratio of
Glu to GABAergic input weight, wGlu=wG, as well as Glu to direct
a4b2 nAChR input weight, wa4b2=wG, to unity. Had we chosen
wGlu~100, wG~1 and wa4b2~1, for example, the DA cell activity
would exhibit no decrease in activity neither in the in vitro nor in
the in vivo scenarios (results not shown). The case wGlu~100,
wG~1 and wa4b2~1 would mean that DA cell activity is
dominated by nicotine driven Glu input increases, giving more
significance to the a7 nAChRs in generating nicotine-dependent
DA responses.
Our analysis reveals key experimental manipulations that would
pinpoint the mechanistic basis for nicotine effects in the VTA:
manipulating the cholinergic drive to the VTA during nicotine
application, and/or changing the nicotine concentration admin-
istered. Decreasing the cholinergic drive to the VTA further boosts
DA activity increases for direct stimulation but diminishes them
for disinhibition (Fig. 5C). The maximal DA response saturates at
low nicotine concentrations (,0.5 mM) for disinhibition, but
continues to rise with higher nicotine concentrations for direct
stimulation (Fig. 5F).
ACh-driven desensitization through low
acetylcholinesterase activity
In all results reported so far, receptor desensitization is driven by
nicotine only. We now investigate what happens if nicotine and
acetylcholine together drive receptor desensitization of the
dominant a4b2 subtype. This might occur whenever acetylcho-
linesterase activity is reduced. In the model, we vary the amount of
ACh contributing to a4b2 nAChR desensitization by the
parameter g and study the impact on GABA and DA neuron
responses for direct stimulation and disinhibition. g varies between
0 - only Nic drives desensitization - and 1 - Nic and the ACh
induce desensitization to equal amounts (see Models).
Direct stimulation is only marginally affected by ACh-driven
desensitization since the a4b2-mediated receptor current predom-
inantly arises from activation through Nic (Fig. 7A,C). The weak
endogenous ACh rate induces initial desensitization which reduces
the steady-state current but also diminishes the amount of further
desensitization through Nic resulting in a negligible net effect (Fig.
S1).
Figure 5. Predicted dynamics of the DA neuron population in the VTA in response to varying cholinergic input rates and Nic
concentrations in case of direct stimulation (A,D) and disinhibition (B,E). Nic was applied for 10 min in the direct stimulation scenario, and
for 2 min in the disinhibition scenario, whereas the endogenous ACh input rate is modeled to be constant (see text). (A&B) Temporal dynamics of DA
neuron activity in response to 1 mM nicotine and varying endogenous cholinergic input rates (ACh range: 0.1-blue lines, 0.5, 1.0, 1.5, 1.77-red lines,
2.0 mM). (C) Maximal increase of DA activity in response to 1.0 mM Nic as a function of the cholinergic input rate (nGlu~0:1, I0~0:1). (D&E) Temporal
dynamics of DA activity in response to 0.5 mM (blue lines) and 3 mM nicotine (red lines) in case of direct stimulation (D, r~0:8, ACh~0:1 mM,
nGlu~0:1, I0~0:0202), or disinhibition (E, r~0, ACh~1:77 mM, nGlu~0:1, I0~0:1). (F) The maximal DA response as a function of applied Nic
concentration is depicted for direct stimulation (orange line) and disinhibition (purple line). Data point (green) adapted from [17].
doi:10.1371/journal.pcbi.1003183.g005
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In contrast, for the disinhibition scenario, the a4b2 nAChR-
mediated current changes from inhibitory to excitatory with
increasing the amount of ACh-driven desensitization (Fig. 7B).
The high endogenous ACh rate induces strong desensitization and
further desensitization by Nic is not enough to overcome receptor
activation (Fig. S1E). In turn, GABA neuron activity is increased
in response to Nic inhibiting DA neuron activity (purple lines in
Fig. 7 B,D).
In summary, acetylcholinesterase activity determines Nic action
for disinhibition but has little effect on direct stimulation. In case
Nic action is mediated through GABAergic neurons (disinhibtion),
varying ACh hydrolysis rates could provide a dynamical means to
control Nic action.
Discussion
The major goal of this study was to determine the dominant
pathway of action for nicotine in the ventral tegmental area. In
order to do so we have developed a novel mesoscopic computa-
tional modeling approach extending a population activity repre-
sentation of the VTA DA and GABA neurons to describe nAChR
responses. This allowed us to clarify the interplay of the
Figure 6. Temporal dynamics of DA neuron activity in response to 1 mM nicotine for 2 min for different values of r and afferent
input strengths. (A) The DA response in the presence of constant low cholinergic and glutamatergic afferent input to the VTA, i.e., in vitro like
conditions (ACh~0:384 mM,nGlu~5:68:10{4). (B) The DA response in the presence of constant high cholinergic and glutamatergic afferent input to
the VTA, i.e., in vivo like conditions (ACh~1:77 mM, nGlu~0:1). In both panels, the distribution of a4b2 nAChRs is changed by varying the control
parameter r in steps of 0.2 from 0 to 1 (as indicated). The examples with values of r as used for the direct stimulation (r~0:8, red) and disinhibition
(r~0, blue) cases in this study are highlighted.
doi:10.1371/journal.pcbi.1003183.g006
Figure 7. Temporal dynamics of GABA and DA neuron activity in response to 1 mM nicotine in case a4b2 receptor desensitization is
driven by Nic and ACh. (A,C) GABA (A) and DA (C) neuron activity in the direct stimulation case (same as in Fig. 4C,E full blue lines; r~0:8,
ACh~0:1 mM, nGlu~0:1, I0~0:0202) for different efficacies of ACh to drive a4b2 receptor desensitization (g given in panel A). (B,D) GABA (B) and DA
(D) neuron activity in the disinhibition case (r~0, ACh~1:77 mM, nGlu~0:1, I0~0:1) for different efficacies of ACh to drive a4b2 receptor
desensitization (g given in panel B, see Models).
doi:10.1371/journal.pcbi.1003183.g007
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pharmacodynamics of nicotine and the dopaminergic signal
constructed in the VTA. Our analysis of the model showed that
in vitro and in vivo data can be reconciled by taking into account the
difference in the afferent input strengths to the VTA in the two
experimental settings: low for in vitro and high for in vivo. The
differential activation and desensitization kinetics of a7- and a4b2
nAChRs combined with different afferent input levels can explain
the mechanism of nicotine action.
However, available experimental data have not allowed to
pinpoint whether a4b2 nAChRs on VTA DA (direct stimulation)
or GABA cells (disinhibition) are the dominant site of nicotine
action in vivo. Using the model, we demonstrate that both
disinhibition and direct stimulation of DA cells can potentially
be at the origin of the experimentally observed nicotine-induced
boost of DA activity in agreement with the recent suggestion that
both receptor activation and desensitization play a role in nicotine
influence [34]. Critically we identify that the endogenous
cholinergic input rate has to be low for direct stimulation, whereas
high cholinergic inputs are crucial in the disinhibition case, in
order to observe a DA activity increase. These results emerge
directly from known activation and desensitization properties of
a4b2 nAChRs.
Several experimental results support the critical role of the
GABAergic cells for the action of nicotine. Most of the cholinergic
axon terminals in the VTA synapse on the non-DA neurons [35].
The a4-containing nAChRs expressed on the VTA GABAergic
neurons upregulate in response to chronic nicotine, potentially
boosting the nicotine control of their activity [28,36]. The
activation of VTA GABA neurons is necessary for the reinforcing
actions of Nic [37]. A wide class of addictive drugs, including
opioids, cannabinoids, c-hydroxy butyrate (GHB), benzodiaze-
pines, lead to inhibition of GABA neurons in the VTA and
thereby disinhibition of DA neurons (e.g, [38], see [39] for an
overview). Furthermore, the GABA antagonist bicuculline is self-
administered by mice [40,41]. Taken together these facts support
the hypothesis that reduced GABAergic input to DA cells can
initiate addictive behaviors. The hyperexcitability of the VTA in
response to nicotine [42] could be related to the higher abundance
of GABAergic cells in the VTA as compared to the SN (GABA to
DA ratio about 1/4 in the VTA [43]; and 1/19 in the substantia
nigra [44]). We would like to point out that the disinhibition
scenario emphasizes the role of local circuitry organization as
opposed to the single cell mechanism associated with direct
stimulation of DA cells. It may also be that disinhibtion is
primarily due to nicotine-induced inhibition of GABA activity of
extrinisic rather than local GABA neurons. Candidates include
GABAergic projections onto DA neurons that arise in the ventral
palladium or the rostromedial tegmental nucleus [45,46].
Our model makes several testable predictions for the case that
the reinforcing properties of nicotine are mediated by inhibition of
the GABA cells. Notably, the DA activity response to Nic is a
mirror-image of the GABAergic firing response (Fig. 4D,F).
Moreover, the DA response to Nic is biphasic: the longer boost is
preceded by a short-lasting inhibtion due to the fast activation of
a4b2 nAChRs (Fig. 4D, and 5B). Some DA neuron recordings
appear to support this observation [47]. We further predict that
the DA boost should saturate at relatively low Nic levels
(,500 nM) in case of disinhibition (Fig. 5F). Higher nicotine
levels do not evoke further increases of DA activity since the
maximal desensitization of a4b2 nAChR is already attained at low
nicotine. This result implies that Nic elicits maximal a4b2
nAChR-mediated increase of DA activity at nicotine concentra-
tions attained in the blood of smokers [11,31].
We confirm previous findings suggesting that physiologically
relevant doses of nicotine do not significantly desensitize a7-
containing nACh receptors [48]. We extend this statement and
propose that physiological concentrations of nicotine do not
significantly activate a7-containing nAChRs. We consider it
therefore unlikely that increased glutamatergic drive to DA cells
in response to nicotine augments their activity. It should however
be noted that the mean-field approach presented here does not
resolve the different firing modes of DA cells, i.e., bursting and
regular firing. a7-containing nAChs could play a role in nicotine
induced bursting [49,50]. The tonic inhibitory input from
GABAergic cells may be setting the overall level of excitability
of DA cells by controling the mean membrane potential. When
the DA cells are disinhibited through desensitization of a4b2
nAChRs, the a7 nAChR activation could induce burst firing on
top of the elevated membrane potential. Hence GABA cells
would gate the DA burst firing, as suggested in a biophysically
detailed model by Komendantov et al. [51]. Furthermore,
bursting induced by a7 nAChR activation could be crucial
for the induction of long-term potentiation of Glu synapses
onto DA cells [18,52]. These topics remain subject of active
investigations.
We note that we focus only on feedforward afferent input
(glutamatergic and cholinergic) and a simplified local circuitry of
the VTA. While we leave aside the possible involvement of other
neuronal structures [46,53], we find that our setup is sufficient to
account for a wide range of data on nicotine/DA interactions.
Furthermore, we chose to not address the potential heterogeneity
of the VTA itself [35,54,55]. However, our proposed circuitry can
be seen either as a global description of the VTA or as a model of a
local computational unit within the VTA. Whether the experi-
mentally observed diversity of DA cell behavior could be explained
by the coexistent presence of direct stimulation and disinhibition
subcircuits or whether recurrent inhibition has to be taken into
account remains an area for future studies. However, already in
our model the activities of the DA and GABAergic cells show a
variety of temporal profiles depending on the a4b2 nAChR
expression and the cholinergic input rate.
Data and theory suggest that dopamine levels modulate
synaptic plasticity and learning [56,57]. Our results together
with this fact lead us to speculate that if salient characteristics of
environmental cues are reflected in the overall cholinergic tone
[58], the nicotine induced increase of phasic DA may explain the
strong associations formed between these cues and the habit of
smoking [59,60].
Our results provide a clear paradigm for understanding the
interactions between endogenous acetylcholine input and the
mechanism by which exogenous nicotine may provoke DA
changes: differential control over the local VTA mechanisms by
endogenous ACh input rates. Endogenous ACh inputs determine
whether Nic evokes a positive DA response or a DA depression for
either scenarios discussed here, i.e., direct stimulation and
disinhibition. For example, nicotine-evoked DA increases and
high ACh input imply disinhibition, while DA increases and low
ACh implicate direct stimulation. Furthermore, taking diural
rhythms of cholinergic signaling into account, the VTA may give
rise to different DA outputs at different times of the day, e.g., the
morning cigarette may deploy different mechanisms than an
evening cigarette. In turn this state-dependency of nicotine-
induced reinforcement could imply that the therapeutic strategies
for smoking cessation may need to be tailored for a variety of
cognitive states in order to act on specific targets within the
predominant pathway of nicotine action.
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Models
In order to examine the mechanisms of nicotine action, we built
a neural population model of the ventral tegmental area
microcircuit using the mean-field approach [61]. Our minimal
local circuit model of the VTA incorporates the glutamatergic
(Glu) and cholinergic (ACh) afferents to the DA and GABA cells in
the VTA, as well as local inhibition of DA cells by GABA neurons
(Fig. 1A). The activation and desensitization of the nAChRs in
response to Nic and ACh were described by a simple 4-state model
adapted from [22,23] (Fig. 1B,C; see Text S2.).
Mean-field description of dopaminergic and GABAergic
VTA neurons
The temporal dynamics of the average activities of dopaminer-
gic and GABAergic neuron populations is characterized by
tD _nD~{nDzW(I0{IGABAzIGluzrIa4b2), ð1Þ
tG _nG~{nGzW(IGluz(1{r)Ia4b2): ð2Þ
vD and vG are the mean firing rates of the DA and GABAergic
neuron populations, respectively. tD and tG are membrane time
constants of the neurons specifying how quickly the neurons
integrate input changes (tD~tG~20 ms). IGlu and Ia4b2 charac-
terize excitatory inputs to both neuron populations mediated by
glutamate receptors and a4b2-containing nAChRs, respectively.
IGABA is the local inhibitory input to DA neurons emanating
from VTA GABAergic neurons. I0 is an intrinsic current of DA
cells giving rise to intrinsic activity in the absence of external
inputs [62]. We further assumed that I0 accounts for other input
sources which are not affected by nicotine and therefore provide
a constant background input (e.g., a6-containing nAChR medi-
ated cholinergic input to DA cells [63]; inhibitory input
originating in other brain regions, etc.). W(I) is the steady-state
current-to-rate transfer function. For simplicity, we assumed that
W(I) is threshold-linear: W(I)~1 if I§0 and W(I)~0 otherwise.
The control parameter r sets the balance of a4b2 nAChR action
through GABAergic or DA cells in the VTA. For r~0: a4b2
containing nAChRs act through GABAergic neurons only,
whereas for r~1: a4b2 receptors influence DA neurons only.
Both neuron populations are influenced by a4b2 nAChRs for
intermediate values of r. In practice, this balance is determined by
the expression level of a4b2 nAChRs, the overall impact of local
GABAergic inputs on DA activity, and by the location of a4b2
nAChRs on the somatodendritic tree of DA and GABAergic
cells.
The input currents in Eqs. (1) and (2) are given by
IGABA~wGnG, ð3Þ
IGlu~wGlu nGluzna7½ 1, ð4Þ
Ia4b2~wa4b2na4b2, ð5Þ
where the wx’s (with x=G, Glu, a4b2) specify the total strength of
the respective input since the activation variables (vG, va7, va4b2)
are normalized to vary between 0 and 1. For our qualitative
investigations, we used wx~1 (with x=G, Glu, a4b2). Inhibitory
input to DA cells, IGABA, depends on the GABAergic neuron
population activity, vG. Glutamatergic input is provided either
by upstream glutamatergic activity, vGlu, or by activation of
a7 nAChRs on presynaptic glutamatergic terminals, va7 (see
below). Nicotine-evoked glutamatergic transmission is indepen-
dent of action potential activation in presynaptic neurons [18].
Hence, either of both inputs can fully activate glutamatergic
transmission
nGluzna7½ 1~
nGluzna7 if nGluzna7ƒ1
1 if nGluzna7w1

: ð6Þ
The activation of a4b2 nAChRs, va4b2 (see next section),
determines the level of direct excitatory input, Ia4b2, evoked by
nicotine or acetylcholine [63].
Modeling the activation and desensitization of nAChRs
driven by Nic and ACh
We implemented nAChR activation and desensitization as
transitions of two independent state variables: an activation gate
and a desensitization gate. This yields four different states of the
nAChR: deactivated/sensitized (also resting or responsive state),
activated/sensitized, activated/desensitized and deactivated/de-
sensitized state (Fig. 1B). Of those states, three are closed and the
activated/sensitized state is the only open state of the receptor in
which it mediates an excitatory current. Note that compared to
other models of allosteric transitions of the nAChR, we chose to
leave aside the rapidly and slowly desensitized states [64], deeper-
level desensitized state or inactivated states [65]. Such states are
collapsed in the desensitized state here. Our model was modified
from the cyclic desensitization model of Katz and Thesleff [22]
where ‘‘effective’’ and ‘‘refractory’’ in their model refer to
sensitized and desensitized here, respectively (see Text S2.).
Assuming independent transitions of the activation and the
desensitization variables entails another simplification compared
to cyclic allosteric transition schemes. In our model, the reaction
rates are the same on opposite sides of the reaction cycle (Fig. 1B),
e.g., the rate from deactivated/sensitized to activated/sensitized is
the same as the transition rate from deactivated/desensitized to
activated/desensitized.
The model accounts for the opening of the channel (transition
from deactivated/sensitive to activated/sensitive, Fig. 1B,C) in
response to both Nic and ACh; while desensitization is driven by
nicotine and ACh if gw0 (transition into the activated/desensi-
tized state, Fig. 1B,C). The inverse transitions, i.e., from activated
to deactivated and from desensitized to sensitized, occur after the
removal of Nic and ACh.
The mean total activation level of nAChRs (va4b2, va7) is
modeled as the product of the fraction of receptors in the activated
state, a, and the fraction of receptors in the sensitized state, s. The
total normalized nAChR activation is therefore vx~ax:sx with
x= a4b2 or a7. The time course of the activation and the
sensitization variables is given by
dy
dt
~(y?(Nic,ACh){y)=ty(Nic,ACh): ð7Þ
where ty(Nic,ACh) refers to the Nic/ACh concentration-depen-
dent time constant at which the asymptotically achievable steady-
state y?(Nic,ACh) is attained. The maximal achievable activation
or sensitization, for a given Nic/ACh concentration,
a?(Nic,ACh) or s?(Nic,ACh) respectively, are given by Hill
equations of the form
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a?(Nic,ACh)~
(AChzaNic)na
EC50
naz(AChzaNic)na
, ð8Þ
s?(Nic,ACh)~
IC50
ns
IC50
nsz(NiczgACh)ns
: ð9Þ
EC50 and IC50 are the half-maximal concentrations of nAChR
activation and sensitization, respectively. The factor a.1 accounts
for the higher potency of Nic to evoke a response as compared to
ACh: aa4b2~3, aa7~2 [26–28,30] (see Fig. 2C,D and Table 1). na
and ns are the Hill coefficients of activation and sensitization. g
varies between 0 and 1 and controls the fraction of the ACh
concentration driving receptor desensitization.
The transition from the deactivated to the activated state is fast
(,ms, ms) [64] compared to the time scales investigated here that
are of the order of seconds to minutes. We therefore simplified the
activation time constant, ta, to be independent of the acetylcho-
line/nicotine concentration, i.e., ta(Nic,ACh)~ta~const:. The
time course of Nic-driven desensitization is characterized by a
concentration-dependent time constant
td(Nic,ACh)~t0ztmax
Kt
nt
Kt
ntz(NiczgACh)nt
: ð10Þ
tmax refers to the recovery time constant from desensitization in
the absence of ligands (tmax&t0). t0 is the fastest time constant at
which the receptor is driven into the desensitized state at high
ligand concentrations. Kt is the concentration at which the
desensitization time constant attains half of its minimum
(tmax&t0). g varies between 0 and 1 and controls the fraction
of the ACh concentration influencing the desensitization time
constant. The parameters describing activation and desensitization
of the two nAChR subtypes were taken from a number of studies
on heterologously expressed human nAChRs and are listed in
Table 1 [25–30]. Note that we used tmax~10 min for a4b2
nAChRs in order to match the time course of DA activity recorded
in vivo, while Fenster et al. [25] recorded a value of tmax~86:9min
in vitro during experiments at room temperature. We adjusted the
minimal time constant by which the receptors are driven into the
desensitized state, t0, such that the model currents qualitatively
captured the experimentally measured time course of nAChR
currents evoked by Nic and ACh [25–30]. This fit yielded a faster
minimal desensitization time constant for the a7 nAChR, i.e.,
10t0
a7~t0
a4b2 (Table 1).
In our simulations, we assumed that both the nicotine bath
application and the intravenous injection imply a slow build-up of
the nicotine concentration at the site of the receptor. That is, the
applied nicotine concentration is not immediately available but
increases/decays exponentially with a time constant of 1 min. The
fast activation of nAChRs, a (transition from deactivated/sensitive
to activated/sensitive, Fig. 1B), was therefore taken to be in steady-
state with the Nic concentration at all times (except in Fig. 2).
Clearly, the above presented simple model of nAChR activation
and desensitization did not resolve all the details of nAChR
kinetics. For example, it was assumed that ACh- and Nic-evoked
responses reach the same maximal amplitude and that, despite
different potencies, Nic and ACh dose-response curves can be
characterized by the same Hill coefficient. These assumptions are
approximately met for a7-containing nAChRs [66]. ACh evokes
however twice the response of Nic with human a4b2 nAChRs in a
study by Chavez-Noriega et al. [66], but the same response
according to other studies [28,67]. We simplified the dose-
response curve using a single Hill equation, rather than using a
sum of two Hill equations as suggested by Buisson and Bertrand
[28]. Nevertheless the simple model presented here captured the
qualitative time course of nAChR currents evoked in response to
Nic and ACh exposures (see Results, [24]). It furthermore
quantitatively accounts for the time course of DA and GABA
neuron activity responses in vivo for single and repetitive Nic
applications [37].
Supporting Information
Figure S1 a4b2 nAChR-mediated current for various
endogenous ACh input rates and ACh-driven desensiti-
zation levels. Three different levels of ACh-driven desensitiza-
tion are considered in the three columns (see top of each column;
see also Model and Methods). (A,C,E) Steady-state activation (a?,
blue) and sensitization (s?, green) curves of the a4b2 nAChR
model (Table 1). The three endogenous ACh input rate cases
depicted in each column are indicated by arrows. (B,D,F, top) The
dynamics of the activation, a, (full lines) and sensitization, s,
(dashed lines) variables in response to 1 mM nicotine for 2 min.
(B,D,F, bottom) The dynamics of the total normalized receptor
current during the nicotine application. The total current is given
by a times s. The three color in (B,D,F) correspond to different
endogenous ACh input rates indicated in A, C, and E in the same
color (A: 0.1, 1.77, 10 mM; B: 0.1, 1.77, 20 mM; C: 0.1, 1.77,
20 mM).
(EPS)
Figure S2 nAChR mediated current in case of no
overlap between the activation and sensitization func-
tions. Same format as in Fig. S1, the mediated current is studied
for various endogenous ACh input rates (shown in cyan, magenta
and gray; see arrows in A,C,E) and three ACh-driven desensiti-
zation levels (see top of each column). (A,C,E) Steady-state
activation (a?, blue) and sensitization (s?, green) curves. The
three endogenous ACh input rate cases depicted in each column
are indicated by arrows. (B,D,F, top) The dynamics of the
activation, a, (full lines) and sensitization, s, (dashed lines) variables
in response to 1 mM nicotine for 2 min. Modified parameters are
IC50~0:01 mM and nd~1, all other parameters are unchanged
from the a4b2 nAChR model (Table 1).
(EPS)
Figure S3 nAChR mediated current in case of a large
overlap between the activation and sensitization func-
tions. Same format as in Fig. S1, the mediated current is studied
for various endogenous ACh input rates (shown in cyan, magenta
and gray; see arrows in A,C,E) and three ACh-driven desensiti-
zation levels (see top of each column). (A,C,E) Steady-state
activation (a?, blue) and sensitization (s?, green) curves. The
three endogenous ACh input rate cases depicted in each column
are indicated by arrows. (B,D,F, top) The dynamics of the
activation, a, (full lines) and sensitization, s, (dashed lines) variables
in response to 1 mM nicotine for 2 min. Modified parameters are
EC50~0:1 mM, IC50~1 mM and nd~1, all other parameters are
unchanged from the a4b2 nAChR model (Table 1).
(EPS)
Figure S4 The different stages in the construction of the
two-gate model for nAChRs. (A) The cyclic model by
Katz and Thesleff (1957) [22]. (B) The two-gate model
mapped onto the Katz-Thesleff model. (C) Separation of the
activation and desensitization gates in the two-gate model. (D)
Generic two-gate model with concentration-dependent rate
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constants. (E) Steady-state curves (‘) and (F) respective time-
constants (t) for the activation (a, black curves) and sensitization
gates (s, grey) of the a7 nAChR. See text for details.
(EPS)
Figure S5 Comparison of the responses generated by
the Katz-Thesleff model and the present two-gate model
for a7 nAChRs. (A) Implementation of the Katz-Thesleff model
following Papke (2010) (see reference list in Text S2). AR* is the
only open state. The rate-constants were hand-tuned to make the
model fit the response trace of the two-gate model during the
application of a 1 s 100 mM ACh pulse (left-lower panel in B). (B)
Response traces of the two-gate model (black curves) and the Katz-
Thesleff model (grey) to varying ACh concentrations. The
indicated concentrations are those used for ACh in the simulation
of the two-gate model. These concentrations were adapted for the
Katz-Thesleff simulations to account for the Hill exponent of two
in the two-gate model, yielding values for [A] of 1.86, 12.5, 100
and 669 mM, respectively. The open-channel probabilities, plotted
on the vertical axes, were calculated as [AR*] for the Katz-
Thesleff model, and as a times s for the two-gate model.
(EPS)
Text S1 Receptor currents for different activation/
sensitization realizations. We investigate in more detail the
a4b2 nAChR mediated current for different levels of ACh-driven
desensitization and varying endogenous ACh input rates. We
furthermore study receptor implementations with qualitatively
different concentration-response profiles for activation and
sensitization. These different realizations can be seen as charac-
terizing other subtypes of nAChRs for which we identify excitatory
and/or inhibitory receptor current regimes with respect to the
ACh input rate and ACh-driven desensitization levels.
(DOCX)
Text S2 From the cyclic Katz-Thesleff model to the two-
gate model. We explain in greater detail the relationship
between the present two-gate model for nAChRs, and the cyclic
Katz-Thesleff model from which it was derived.
(DOCX)
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